1330 cd 050 cf (R&D Systems)
Structured Review
1330 Cd 050 Cf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 11 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd32a/Recombinant+Human+Fc+gamma+RIIA%2FCD32a+(R167)+Protein/us12473363-2012-15-16
Average 93 stars, based on 11 article reviews
Images
Related Articles
K-Buffer:Article Title: RUBY® – a tetravalent (2+2) bispecific antibody format with excellent functionality and IgG-like stability, pharmacology and developability properties Article Snippet: .. RUBY bsAb and monoclonal isotype controls were diluted to 200 nM in 1× Kinetic buffer and captured on 8 parallel sensors for 300 sec. After setting a new baseline, the captured antibodies were assayed against any of the FcγR (hFcγRI (1257-FC-050, R&D Systems), Recombinant:Article Title: Bispecific antibody for ICOS and PD-L1 Article Snippet: The recombinant human FcγRIIIa (4325-FC-050, R&D Systems) and mouse FcγRIII (1960-FC-050, R&D Systems) were diluted to 2 μM in running buffer. .. Finally, the Article Title: Humoral signatures of Caspr2-antibody spectrum disorder track with clinical phenotypes and outcomes. Article Snippet: Article Article Title: Anti-CD38 antibodies and methods of use Article Snippet: .. Materials and Methods C-terminal 6-His tagged recombinant Article Title: M9657 Is a Bispecific Tumor-Targeted Anti-CD137 Agonist That Induces MSLN-Dependent Antitumor Immunity without Liver Inflammation Article Snippet: M9657 Is a Bispecific Tumor-Targeted Anti-CD137 Agonist That Induces MSLN-Dependent Antitumor Immunity without Liver Inflammation Chunxiao Xu, Xueyuan Zhou, Lindsay Webb, Sireesha Yalavarthi, Wenxin Zheng, Somdutta Saha, Rene Schweickhardt, Maria Soloviev, Molly H. Jenkins, Susanne Brandstetter, Natalya Belousova, Marat Alimzhanov, Brian Rabinovich, Amit M. Deshpande, Neil Brewis, and Laura Helming Cell Isolation:Article Title: Humoral signatures of Caspr2-antibody spectrum disorder track with clinical phenotypes and outcomes. Article Snippet: Article other:Article Title: NK/monocyte engagers Article Snippet: Serially diluted GEM-DIMERs and antibodies (final concentration: 10.2-60,000 pM) were preincubated in medium containing 2 μg/mL actinomycin D and 20 IU/mL of human TNF-α for 30 min at 37° C. The cells were incubated for an additional 20 h at 37° C. and cell viability was analyzed using CellTiter-Glo, Cat #G7573 (Promega, Madison, WI), according to the manufacturer's recommendations. Binding Assay:Article Title: Antigenic peptide delivery to antigen-presenting cells using a CD40-coiled coil affinity-based platform Article Snippet: Antibodies or antibody-peptide complexes were captured on 8 parallel Anti-Fab 2nd generation (FAB2G) sensors (Sartorius) for 300s. .. After setting a new baseline, the binding of human FcγRI (1257-FC, R&D Systems), FcγRIIa-H167 (9595-CD, R&D Systems), Concentration Assay:Article Title: M9657 Is a Bispecific Tumor-Targeted Anti-CD137 Agonist That Induces MSLN-Dependent Antitumor Immunity without Liver Inflammation Article Snippet: M9657 Is a Bispecific Tumor-Targeted Anti-CD137 Agonist That Induces MSLN-Dependent Antitumor Immunity without Liver Inflammation Chunxiao Xu, Xueyuan Zhou, Lindsay Webb, Sireesha Yalavarthi, Wenxin Zheng, Somdutta Saha, Rene Schweickhardt, Maria Soloviev, Molly H. Jenkins, Susanne Brandstetter, Natalya Belousova, Marat Alimzhanov, Brian Rabinovich, Amit M. Deshpande, Neil Brewis, and Laura Helming |
